Details for 2018758120

Up to date per 04.04.2026

Actions

Title / Product Name

THERAPIE VON KLEINZELLIGEM LUNGENKARZINOM (SCLC) MIT EINEM GEGEN TROP-2 GERICHTETEN TOPOISOMERASE-I-HEMMENDEN ANTIKÖRPER-WIRKSTOFF-KONJUGAT (ADC)

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018758120

EP Publication Number

3585442

E-Number

1619568

Language

PCT Number

US18019025

Publication Date

01.01.2020 A

11.10.2023 B1

Registration Date

11.10.2023

AT Publication Date

15.11.2023

Application Date

21.02.2018

Registration Number

Priorities

24.02.2017

201762463316 P

22.11.2017

201715820708

IPC

A61K 47/68 20170101AFI20200804BHEP

Maximum Duration of Protection

21.02.2038

Owner

Immunomedics, Inc.300 American Road Morris Plains, NJ 07950US

Representative

No representatives present

Inventor

GOLDENBERG, David M.300 American Road Morris Plains, New Jersey 07950US

GOVINDAN, Serengulam V.300 American Road Morris Plains, New Jersey 07950US